Century Therapeutics Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9,222.3% | -9,787.3% | -3,537.8% | -3,545.0% | -3,581.8% | -580.5% | -31.7% | – | – | – | – | – | – | |
| 2,263.5% | 1,325.4% | 377.3% | 449.0% | 416.9% | 79.5% | 3.0% | – | – | – | – | – | – | |
| 2,687.8% | 1,329.1% | 375.1% | 454.3% | 419.5% | 63.7% | 2.2% | – | – | – | – | – | – | |
| 8,229.7% | -1,086.2% | -1,058.0% | 92.5% | -104.8% | 43.9% | -106.7% | – | – | – | – | – | – | |
| 2,206.1% | 365.7% | 63.0% | 34.4% | 104.3% | 3.7% | 0.4% | – | – | – | – | – | – | |
| 2,849.3% | 6,941.4% | 1,349.8% | -4,392.2% | 4,955.6% | 733.4% | 25.6% | – | – | – | – | – | – | |
| – | -132.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 202.7% | -132.8% | 2,128.1% | 7,353.7% | 34.5% | -14.4% | 0.1% | – | – | – | – | – | – | |
| -6,170.3% | -2,978.7% | -59.9% | -583.5% | 1,408.3% | 140.1% | -6.0% | – | – | – | – | – | – | |
| -11,428.4% | -10,153.0% | -3,600.8% | -3,579.4% | -3,477.5% | -584.2% | -32.2% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.